- cafead   Jun 04, 2024 at 12:03: PM
via After Amarin's tussle with investor group Sarissa Capital led to a restructuring and a board shuffle, the struggling drugmaker is undergoing its third CEO shake-up in just over a year.
This time, the company is giving a familiar face the official CEO title, tapping former interim chief Aaron Berg for the post.
article source
This time, the company is giving a familiar face the official CEO title, tapping former interim chief Aaron Berg for the post.
article source